Barry has enjoyed a diverse career beginning in community pharmacy and moving into regional and remote hospital pharmacy in WA and far North QLD.


Dr Ghaly is Head of the Inflammatory Bowel Disease Service and Staff Specialist at St. Vincent’s Hospital, Sydney. He is also a lecturer at the School of Medicine, UNSW Sydney.


Dr Thin is a consultant gastroenterologist at Fiona Stanley Hospital, a position she has held for 8 years. Dr Thin is the lead clinical trials investigator for the IBD unit.

Australia has a strong regulatory system for all medicines

Australia has a strong regulatory system that ensures the safety, effectiveness and quality of all medicines, including biological medicines.

Biosimilar medicines are used to treat the same diseases in the same way

A biosimilar medicine is a highly similar version of an original brand of a biological medicine, brought to market by a different manufacturer once the patent on the original brand expires.

Chief Pharmacist, Royal Marsden NHS Foundation Trust

Jatinder Harchowal provides an international perspective on the use of biosimilar medicines in the United Kingdom.